Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Treasury Shares (2016 - 2023)

Alaunos Therapeutics (TCRT) has disclosed Treasury Shares for 13 consecutive years, with $437500.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Treasury Shares rose 2233.33% year-over-year to $437500.0, compared with a TTM value of $437500.0 through Sep 2023, up 2233.33%, and an annual FY2022 reading of $1250.0, down 98.44% over the prior year.
  • Treasury Shares was $437500.0 for Q3 2023 at Alaunos Therapeutics, down from $657187.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.6 million in Q3 2019 and bottomed at $1250.0 in Q4 2022.
  • Average Treasury Shares over 5 years is $819287.0, with a median of $946002.0 recorded in 2022.
  • The sharpest move saw Treasury Shares tumbled 98.76% in 2022, then surged 2233.33% in 2023.
  • Year by year, Treasury Shares stood at $1.6 million in 2019, then tumbled by 49.91% to $786280.0 in 2020, then tumbled by 89.84% to $79905.0 in 2021, then plummeted by 98.44% to $1250.0 in 2022, then surged by 34900.0% to $437500.0 in 2023.
  • Business Quant data shows Treasury Shares for TCRT at $437500.0 in Q3 2023, $657187.0 in Q2 2023, and $898125.0 in Q1 2023.